CBD or cannabidiol is a substance of the cannabinoid group, the phytocannabinoids, which means that the substance is naturally present in the hemp plant. This plant contains molecules with natural properties known since the dawn of time, still today, and mainly thanks to two of them: THC and CBD. Both present in the plant in different proportions depending on the variety. Until recently, the interest was on THC. Most of the existing plant varieties have a high THC content and a low CBD content because the use of the plant was mostly recreational. THC and CBD do not have the same effects.

Care must be taken not to confuse cannabidiol with tetrahydrocannabinol (THC) and cannabinol (CBN) that belong to the same group, but are very different. Cannabidiol (CBD) is a substance present in cannabis, a relative of THC. Numerous scientific studies demonstrate a variety of effects (both on brain and tissue) of CBD on the human body, since CBD interacts with cannabinoid receptors in the body, by activating and improving the body’s natural response to pain, anxiety, stress, concentration and energy. CBD is not a psychoactive substance. That is, there is no direct effect on the nervous system and it is not addictive.

It was within neuropsychiatric research (mainly on epilepsy and schizophrenia) that science got interested in CBD, and much of what is known today derives from that scientific work. The treatments used previously did not give results, but rather multiple side effects, so medical research decided to explore cannabinoids. Studies have yielded excellent results without a change in the metabolism of the human body. A good first point for CBD. It’s been many years since we first heard about medical research employing cannabis for medical purposes. CBD is one of the results of many years of research. This is probably the reason why it will be much more difficult to legislate on this substance which, unlike nicotine, has been developed mainly in a medical environment.